Safety and Efficacy of the Vibrant Soundbridge (VSB) for Mixed and Conductive Hearing Losses

NCT00748540 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-09-25

Study results available
· View outcomes & findings →

Summary

The purpose of this investigation is to collect feasibility data to assess the safety and efficacy of the Vibrant Soundbridge (VSB), a medical device designed to provide benefit in aided hearing thresholds, speech perception and sound quality to certain individuals with hearing loss with minimal changes in residual hearing. The VSB is currently indicated for adults with moderate-to-severe sensorineural hearing loss. Under the present investigation, adults with conductive and mixed hearing losses who are not successful users of traditional amplification will be assessed.

Conditions

Interventions

DEVICE

Vibrant Soundbridge

Mixed and conductive hearing loss using round window stimulation

Sponsors & Collaborators

  • Med-El Corporation

    lead INDUSTRY

Principal Investigators

  • David Foyt, MD · Capital Region Ear Institute

  • Jose Fayad, MD · House Ear Institute

  • Jennifer Maw, MD · Jennifer Maw, MD

  • Robert Cullen, MD · Midwest Ear Institute

  • Douglas Chen, MD · Pittsburgh Ear Associates

  • Jack Wazen, MD · Silverstein Institute

  • Hinrich Staecker, MD, PhD · University of Kansas Medical Center

  • Fred Telischi, MD · University of Miami

  • Craig Buchman, MD · University of North Carolina Hospital

  • Peter Roland, MD · University of Texas Southwestern Medical Center

  • Richard Wiet, MD · Ear Institute of Chicago

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00748540 on ClinicalTrials.gov